IL6 and esophageal squamous cell carcinoma: Indeed, Suchi et al showed using ESCC cell lines KYSE170 and TE13 that the expression of IL-6 in esophageal carcinoma cells may act as a resistance factor against CDDP-based chemotherapy or chemo-radio-therapy (23).